Amgen battles for EPO in Congress

Nat Biotechnol. 1998 Nov;16(11):999-1000. doi: 10.1038/3440.
No abstract available

Publication types

  • News

MeSH terms

  • Biotechnology / legislation & jurisprudence*
  • Erythropoietin / genetics*
  • Humans
  • Legislation, Drug
  • Patents as Topic*
  • Recombinant Proteins

Substances

  • Recombinant Proteins
  • Erythropoietin